Xeris Biopharma Holdings, Inc. (XERS)
6.24
-0.14
(-2.19%)
USD |
NASDAQ |
May 15, 16:00
6.245
0.00 (0.00%)
After-Hours: 20:00
Xeris Biopharma Holdings EPS Diluted (Quarterly) : 0.0126 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Zoetis, Inc. | 1.423 |
| Harrow, Inc. | -0.7414 |
| Corcept Therapeutics, Inc. | -0.2988 |
| Assertio Holdings, Inc. | -2.931 |
| Johnson & Johnson | 2.141 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 2.234M |
| Revenue (Quarterly) | 83.13M |
| Total Expenses (Quarterly) | 80.89M |
| Enterprise Value | 1.224B |
| Gross Profit Margin (Quarterly) | 84.02% |
| Profit Margin (Quarterly) | 2.69% |
| Earnings Yield | 1.05% |
| Operating Earnings Yield | 3.31% |
| Normalized Earnings Yield | 1.050 |